Autoimmune & Immunology
Given autoimmune disorders are one the largest healthcare burdens after oncology, and the current standard of care risking infection and low efficacy, the demand and opportunity to develop precision therapies is growing. It is therefore hugely promising that 506 trials were initiated in H1 2024 alone to pioneer future innovations needed by patients.
With a specific focus on cell therapies, Tregs, immune tolerance, cytokines and targeting the inflammasome and complement pathways, our mission is to help organisations uncover translational opportunities to accelerate the development and approval of more precise therapies that address the patient health burden associated with autoimmunity.
Bring Safe, Effective & More Precise Therapies to Autoimmune Patients Faster
The field of Autoimmune research is rapidly expanding into novel modalities and scientific breakthroughs from the fields of oncology and immunotherapy, are rapidly being applied to autoimmune disorders. With over 2800 active biopharma companies in the immune-mediated disease space, with over 4000 active drugs in development, it is incredibly difficult to stay up to date and understand the latest applications.
From exclusive industry dedicated conferences, to curated Immune Tolerance clinical trial and drug database solution, we will bring you a diverse set of focused opportunities access scientific advancements, solve shared challenges, and make meaningful connections with fellow scientists who are innovating the next generation of more targeted, effective and precise therapies to tackle autoimmune disorders.
Featured Autoimmune & Immunology Products
Autoimmune & Immunology Products by Type
CONTACT US
Get in touch
We speak to hundreds of biopharmaceutical experts from industry and academia every day. We would love for you to be one of them. Contact us to discover how our events can accelerate your drug development.
Standard Form - Autoimmune & Immunology
"*" indicates required fields